Role of Local Radiation Therapy in Cancer Immunotherapy
- PMID: 26270858
- DOI: 10.1001/jamaoncol.2015.2756
Role of Local Radiation Therapy in Cancer Immunotherapy
Abstract
The recent success of cancer immunotherapy has demonstrated the power of the immune system to clear tumors, generating renewed enthusiasm for identifying ways to induce antitumor immune responses in patients. Natural antitumor immune responses are detectable in a fraction of patients across multiple malignant neoplasms and can be reactivated by targeting rate-limiting immunosuppressive mechanisms. In most patients, however, interventions to induce a de novo antitumor immune response are necessary. We review growing evidence that radiation therapy targeted to the tumor can convert it into an in situ tumor vaccine by inducing release of antigens during cancer cell death in association with proinflammatory signals that trigger the innate immune system to activate tumor-specific T cells. In addition, radiation's effects on the tumor microenvironment enhance infiltration of activated T cells and can overcome some of the barriers to tumor rejection. Thus, the complementary effects of radiation on priming and effector phases of antitumor immunity make it an appealing strategy to generate immunity against a patient's own individual tumor, that through immunological memory, can result in long-lasting systemic responses. Several anecdotal cases have demonstrated the efficacy of combining radiation with available immunotherapies, and results of prospective trials are forthcoming.
Comment in
-
Brain Metastases From Melanoma: Therapy at the Crossroads.Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):713-716. doi: 10.1016/j.ijrobp.2016.06.005. Int J Radiat Oncol Biol Phys. 2016. PMID: 27788943 No abstract available.
Similar articles
-
Combining radiotherapy and immunotherapy: a revived partnership.Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):655-66. doi: 10.1016/j.ijrobp.2005.06.032. Int J Radiat Oncol Biol Phys. 2005. PMID: 16199306 Free PMC article. Review.
-
Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.Cancer Sci. 2015 Feb;106(2):134-42. doi: 10.1111/cas.12584. Epub 2015 Jan 16. Cancer Sci. 2015. PMID: 25483888 Free PMC article.
-
Irradiation Enhances Abscopal Anti-tumor Effects of Antigen-Specific Immunotherapy through Regulating Tumor Microenvironment.Mol Ther. 2018 Feb 7;26(2):404-419. doi: 10.1016/j.ymthe.2017.11.011. Epub 2017 Nov 21. Mol Ther. 2018. PMID: 29248428 Free PMC article.
-
The Impact of Radiation Therapy on Innate and Adaptive Tumor Immunity.Semin Radiat Oncol. 2020 Apr;30(2):139-144. doi: 10.1016/j.semradonc.2019.12.005. Semin Radiat Oncol. 2020. PMID: 32381293 Review.
-
Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.Curr Opin Oncol. 2015 Nov;27(6):445-51. doi: 10.1097/CCO.0000000000000225. Curr Opin Oncol. 2015. PMID: 26447875 Review.
Cited by
-
Nano-Assisted Radiotherapy Strategies: New Opportunities for Treatment of Non-Small Cell Lung Cancer.Research (Wash D C). 2024 Jul 23;7:0429. doi: 10.34133/research.0429. eCollection 2024. Research (Wash D C). 2024. PMID: 39045421 Free PMC article. Review.
-
Proposing synchronous oligometastatic non-small-cell lung cancer based on progression after first-line systemic therapy.Cancer Sci. 2021 Jan;112(1):359-368. doi: 10.1111/cas.14707. Epub 2020 Nov 11. Cancer Sci. 2021. PMID: 33098119 Free PMC article.
-
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma.J Clin Oncol. 2021 Jan 1;39(1):30-37. doi: 10.1200/JCO.20.00290. Epub 2020 Aug 21. J Clin Oncol. 2021. PMID: 32822275 Free PMC article. Clinical Trial.
-
Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy.J Exp Clin Cancer Res. 2024 Sep 2;43(1):251. doi: 10.1186/s13046-024-03165-x. J Exp Clin Cancer Res. 2024. PMID: 39218928 Free PMC article.
-
A tumor-immune interaction model for hepatocellular carcinoma based on measured lymphocyte counts in patients undergoing radiotherapy.Radiother Oncol. 2020 Oct;151:73-81. doi: 10.1016/j.radonc.2020.07.025. Epub 2020 Jul 15. Radiother Oncol. 2020. PMID: 32679308 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources